Health Economics (Health Economics)

Health economics emerged as a distinct subfield in the mid-20th century, fundamentally concerned with the application of economic theory and methods to understand behavior and outcomes in health and medical care. Its central questions revolve around the determinants of health, the demand for healthcare, the behavior of providers, the functioning of health insurance markets, and the evaluation of health policies and technologies. Its evolution is characterized by the adaptation and contestation of core economic paradigms to the unique institutional and ethical features of the health sector.

The foundational phase was dominated by the application of Neoclassical Welfare Economics and Human Capital Theory. Seminal works by Kenneth Arrow in 1963 formalized the health sector's deviations from the standard competitive model, highlighting uncertainty, asymmetric information, and externalities as central market failures. This established a paradigm of Market Failure Analysis in Healthcare, which justified government intervention and shaped policy analysis for decades. Concurrently, the Human Capital Approach, pioneered by Gary Becker and Jacob Mincer, framed health as a durable capital stock, transforming health investment into a problem of intertemporal choice and providing a theoretical basis for valuing health gains in economic terms.

The 1970s and 1980s saw the rise of the Newhouse Model of the Hospital and the formalization of Health Insurance Theory, heavily influenced by Asymmetric Information Economics. The work of Michael Rothschild and Joseph Stiglitz on adverse selection crystallized into a dominant framework for analyzing insurance markets, while the principal-agent problem became the lens for understanding physician-patient relationships. This period also solidified Cost-Effectiveness Analysis (CEA) and Cost-Benefit Analysis (CBA) as the dominant Welfarist Evaluation Paradigms for health technology assessment, operationalizing welfare economics into practical decision-making tools, though often relying on extra-welfarist foundations like the quality-adjusted life year (QALY).

Methodologically, the subfield was revolutionized by the Microeconometrics revolution. The adoption of the Design-Based Approach and causal inference methods—instrumental variables, difference-in-differences, and later, regression discontinuity designs—shifted empirical work from descriptive associations toward causal claims about policy impacts. This Credibility Revolution in Health Economics established a new methodological standard, often rivaling or supplementing traditional Structural Econometric models that sought to estimate deep behavioral parameters for counterfactual simulation.

The late 20th and early 21st centuries introduced significant paradigm challenges. Behavioral Health Economics emerged, applying insights from Prospect Theory and bounded rationality to critique the standard model of rational health investment and insurance choice, explaining phenomena like inertia, present bias, and framing effects in health decisions. Simultaneously, the Political Economy of Health Policy school gained prominence, shifting focus from technical efficiency to the role of institutions, interest groups, and ideology in shaping health systems, drawing from Public Choice Theory and New Institutional Economics.

The current landscape is pluralistic. The Extra-Welfarist Framework, which evaluates outcomes based on health capabilities rather than individual utilities, stands as a major rival to the traditional Welfarist foundation of CBA. Empirical Industrial Organization (IO) methods are now a central paradigm for analyzing competition and regulation in hospital and pharmaceutical markets. While Neoclassical Microeconomic Theory remains the core analytical engine, it is now routinely integrated with, and challenged by, behavioral insights, rigorous microeconometric identification, and institutional analysis. The central tension persists between designing optimal policies under idealized assumptions and understanding the functioning and political constraints of real-world health systems.